ADORA2A and Parkinson disease: It could then be hypothesized that, in pathological conditions, in which impairment of the D2R-A2AR oligomer would occur (i.e. PD), the well-known D2R-A2AR transinhibition (for a review, see Ferré et al., 1997; Fuxe et al., 2010) would be reduced.